Hannele Uusitalo-Jarvinen
Overview
Explore the profile of Hannele Uusitalo-Jarvinen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
347
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hujanen P, Tuulonen A, Leinonen S, Vepsalainen K, Johannesson G, Vaajanen A, et al.
Acta Ophthalmol
. 2025 Feb;
PMID: 39943889
Purpose: The purpose of this study was to create a prototype master protocol for benchmarking glaucoma real-world data (RWD). Benchmarking is part of the digital innovation strategy of the Finnish...
2.
Pemmari T, Prince S, Wiss N, Koiv K, May U, Molder T, et al.
Life Sci Alliance
. 2025 Feb;
8(5).
PMID: 39933917
In vivo phage display is a method used for identification of organ- or disease-specific vascular homing peptides for targeted delivery of pharmaceutics. It is agnostic as to the nature and...
3.
Tuulonen A, Kim T, Chauhan B, Burgoyne C, Saarela V, Uusitalo-Jarvinen H
Acta Ophthalmol
. 2024 Jan;
102(4):e646-e650.
PMID: 38243372
No abstract available.
4.
Sulonen S, Leinonen S, Lehtonen E, Hujanen P, Vaajanen A, Syvanen U, et al.
Acta Ophthalmol
. 2023 Sep;
102(2):216-227.
PMID: 37753831
Purpose: As the first step in monitoring and evaluating day-to-day glaucoma care, this study reports all real-world data recorded during the first full year after the implementation of a prototype...
5.
Hujanen P, Ruha H, Lehtonen E, Pirinen I, Huhtala H, Vaajanen A, et al.
BMJ Open Ophthalmol
. 2023 Aug;
8(1).
PMID: 37586826
Background/aims: To analyse long-term outcomes of antivascular endothelial growth factor (anti-VEGF) therapy for the treatment of neovascular age-related macular degeneration (nAMD) using pro re nata (PRN) regimen in a single-centre...
6.
Vahatupa M, Nattinen J, Aapola U, Uusitalo-Jarvinen H, Uusitalo H, Jarvinen T
Int J Mol Sci
. 2023 May;
24(9).
PMID: 37175621
Small GTPase R-Ras regulates vascular permeability in angiogenesis. In the eye, abnormal angiogenesis and hyperpermeability are the leading causes of vision loss in several ischemic retinal diseases such as proliferative...
7.
Pirinen I, Leinonen S, Helminen M, Hujanen P, Vaajanen A, Tuulonen A, et al.
Acta Ophthalmol
. 2022 Nov;
101(3):261-265.
PMID: 36398433
Purpose: The purpose of this study was to investigate how often glaucoma and neovascular age-related macular degeneration (nAMD) occur in the same patient and to evaluate whether glaucoma progression is...
8.
Hujanen P, Vaajanen A, Felin T, Lehtonen E, Syvanen U, Huhtala H, et al.
Br J Ophthalmol
. 2022 Oct;
107(12):1782-1786.
PMID: 36229178
Background/aims: To assess the frequency of immediate sequential bilateral cataract surgery (ISBCS) and endophthalmitis during 13-year period in Tays Eye Centre, Tampere University Hospital, Tampere, Finland. Methods: All cataract surgeries...
9.
Vahatupa M, Salonen N, Uusitalo-Jarvinen H, Jarvinen T
Pharmaceutics
. 2021 Nov;
13(11).
PMID: 34834347
Pathological angiogenesis is the hallmark of ischemic retinal diseases among them retinopathy of prematurity (ROP) and proliferative diabetic retinopathy (PDR). Oxygen-induced retinopathy (OIR) is a pure hypoxia-driven angiogenesis model and...
10.
Tuulonen A, Kataja M, Aaltonen V, Kinnunen K, Moilanen J, Saarela V, et al.
Acta Ophthalmol
. 2021 Jul;
100(3):e833-e840.
PMID: 34263537
This paper describes a holistic, yet simple and comprehensible, ecosystem model to deal with multiple and complex challenges in eyecare. It aims at producing the best possible wellbeing and eyesight...